Sale

In Silico Clinical Trials Market

Global In Silico Clinical Trials Market Size, Price, Share, Forecast: By Industry Type: Medical Devices, Pharmaceuticals; By Therapeutic Area: Oncology, Infectious Disease, Hematology, Cardiology, Dermatology, Neurology, Diabetes, Others; By Phase: Phase I, Phase II, Phase III, Phase IV; Regional Analysis; Supplier Landscape; 2024-2032

Global In Silico Clinical Trials Market Outlook

The global in silico clinical trials market size was valued at USD 3.33 billion in 2023, driven by the rise in demand of personalized medicine across the globe. The market is anticipated to grow at a CAGR of 7.42% during the forecast period of 2024-2032 to achieve a value of USD 6.34 billion by 2032.

 

In Silico Clinical Trials: Introduction

In silico clinical trials are used to perform tests and trials pre-launch of drugs and medicines in the market. The in silico clinical trials, which are also known as virtual clinical trials, are used to perform clinical tests without harming any human or animal. In these clinical trials computer-based models and simulations are used to know about the safety, accuracy, efficiency and outcomes of the treatment before sending them under real trials. With the help of in silico clinical trials, time consumption in comparison to the real trials is less. In in silico clinical trials, the imitation of real medicines takes place, which is further utilized to personalize treatment process and develop personalize treatment plan. It also helps in speeding up the development process of the drug and the time when it would be active in the body.

 

Global In Silico Clinical Trials Market Analysis

The increasing focus on potential of in silico clinical trials in the development process of drug as it provides useful insights before the real human trials, is expected to aid the in-silico clinical trials market growth. This process has the potential of reducing the time, expenditure and effectiveness of the drug development process.

 

Additionally, with the help of in silico clinical trials combined with the patient-specific data, such as medical symptoms from past or genetic data, in order to generate personalized medicine will directly contribute to the market growth. The increasing technological development in the healthcare industry and specifically in in-silico clinical trials has been creating a huge impact on the market as well, propelling the global in-silico clinical trials market expansion. Advanced technologies like artificial intelligence and machine learning are used to perform in-silico clinical trials in order to achieve more accuracy and by processing data which would not be possible to process easily with the use of other traditional methods.

 

Global In Silico Clinical Trials Market Segmentations

Market Segmentation by Industry

  • Medical Devices 
  • Pharmaceuticals

 

Market Breakup by Therapeutic Area

  • Oncology 
  • Infectious Disease 
  • Hematology 
  • Cardiology 
  • Dermatology
  • Neurology
  • Diabetes 
  • Others

 

Market Breakup by Phase

  • Phase I 
  • Phase II 
  • Phase III 
  • Phase IV

 

Market Breakup by Region

  • North America  
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

 

Global In Silico Clinical Trials Market Overview

The major factors driving the market growth include the involvement of advanced technologies such as artificial intelligence and machine learning to achieve more accuracy in the outcomes of these trials. More accuracy will result in the development of more effective drugs and medicines. In-silico clinical trials saves time and are cost-effective as well as they are not being performed on real humans or animals but virtual patients.

 

Additionally, the continuous development to increase the efficiency of software used in the systems for these trials also contributes to the technological advancement in in-silico clinical trials. The market is growing steadily from past few years and is expected to keep growing steadily in future as well. In silico clinical trials helps researchers to simulate the drug responses in virtual patient populations which further helps in the development of personalized medicine approaches and facilitates the optimization of drug regimens for particular patient populations and improving treatment outcomes further contributing to the global in-silico clinical trials market expansion.

 

Global in Silico Clinical Trials Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Dassault Systèmes SE 
  • Certara Inc. 
  • Insilico Medicine 
  • GNS Healthcare Inc. 
  • The AnyLogic Company 
  • Novadiscovery SAS 
  • InSilicoTrials Technologies SpA 
  • Immunetrics Inc. 
  • CATO SMS 
  • Evotec SE

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Industry Type
  • Therapeutic Area
  • Phase
  • Region
Breakup by Industry Type
  • Medical Devices 
  • Pharmaceuticals
Breakup by Therapeutic Area
  • Oncology 
  • Infectious Disease 
  • Hematology 
  • Cardiology 
  • Dermatology
  • Neurology
  • Diabetes 
  • Others
Breakup by Phase
  • Phase I 
  • Phase II 
  • Phase III 
  • Phase IV
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Dassault Systèmes SE 
  • Certara Inc. 
  • Insilico Medicine 
  • GNS Healthcare Inc. 
  • The AnyLogic Company 
  • Novadiscovery SAS 
  • InSilicoTrials Technologies SpA 
  • Immunetrics Inc. 
  • CATO SMS 
  • Evotec SE

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global In Silico Clinical Trials Market Overview
 
    3.1    Global In Silico Clinical Trials Market Historical Value (2017-2023) 
    3.2    Global In Silico Clinical Trials Market Forecast Value (2024-2032)
4    Global In Silico Clinical Trials Market Landscape
    4.1    Global In Silico Clinical Trials Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global In Silico Clinical Trials Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Indications
        4.2.3    Analysis by Phase
5    Global In Silico Clinical Trials Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global In Silico Clinical Trials Market Segmentation 
    6.1    Global In Silico Clinical Trials Market by Industry Type
        6.1.1    Market Overview
        6.1.2    Medical Devices
        6.1.3    Pharmaceuticals
    6.2    Global In Silico Clinical Trials Market by Therapeutic Area
        6.2.1    Market Overview
        6.2.2    Oncology
        6.2.3    Infectious Disease
        6.2.4    Hematology
        6.2.5    Cardiology
        6.2.6    Dermatology
        6.2.7    Neurology
        6.2.8    Diabetes
        6.2.9    Others
    6.3    Global In Silico Clinical Trials Market by Phase
        6.3.1    Market Overview
        6.3.2    Phase I
        6.3.3    Phase II
        6.3.4    Phase III
        6.3.5    Phase IV
    6.4    Global In Silico Clinical Trials Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America In Silico Clinical Trials Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe In Silico Clinical Trials Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific In Silico Clinical Trials Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America In Silico Clinical Trials Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa In Silico Clinical Trials Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Dassault Systèmes SE
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Certara Inc.
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Insilico Medicine
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    GNS Healthcare Inc.
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    The AnyLogic Company
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Novadiscovery SAS
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    InSilicoTrials Technologies SpA
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Immunetrics Inc.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    CATO SMS
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Evotec SE
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certificationsa
18    Global In Silico Clinical Trials Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 3.33 billion in 2023, driven by the increased integration of advanced technologies in the market.

The market is anticipated to grow at a CAGR of 7.42% during the forecast period of 2024-2032 to reach a market value of USD 6.34 billion by 2032.

The increasing demand for personalized medicine across the globe is among the major drivers for the market.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

The different types of industries in the market include medical devices and pharmaceuticals.

The different therapeutic areas in the market are oncology, infectious disease, hematology, cardiology, dermatology, neurology, and diabetes, among others.

The end users in the market include hospitals and clinics, diagnostic centres, academic research institutions, among others.

The different phases of the trials are Phase I, Phase II, Phase III, and Phase IV.

The adoption of new technologies such as artificial intelligence and machine learning in in-silico clinical trials is among the major key trends in the market.

Key players involved in the market are Dassault Systèmes SE, Certara Inc., Insilico Medicine, GNS Healthcare Inc., The AnyLogic Company, Novadiscovery SAS, InSilicoTrials Technologies SpA , Immunetrics Inc., CATO SMS, and Evotec SE.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER